CLINICAL_TRIALS trial_result · 2014-08-18

Clinical Trial Update: Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia [NA]

Clinical trial of Rituximab for relapsed acute lymphoblastic leukemia was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Emory University | Conditions: Leukemia, Acute Lymphoblastic Leukemia | NA | Status: TERMINATED | Results posted: 2014-08-18